Clinical Manifestations
Post-COVID19 syndrome is characterized by signs and symptoms that occur within 3 months of the onset of COVID19 acute phase and last at least 2 months. In the past 3 years, cognitive impairment has frequently been associated with COVID19 with descriptions of attentional, executive, memory, and langu...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 Suppl 3, p.e091999 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | e091999 |
container_title | Alzheimer's & dementia |
container_volume | 20 Suppl 3 |
creator | Spera, Raphael Ribeiro de Luca E Tuma, Raphael Rodrigues, Júlia Chartouni Peixoto, Satiko Andrezza Takano Neto, Adalberto Studart Miotto, Eliane C Coutinho, Artur Martins Brucki, Sonia Maria Dozzi |
description | Post-COVID19 syndrome is characterized by signs and symptoms that occur within 3 months of the onset of COVID19 acute phase and last at least 2 months. In the past 3 years, cognitive impairment has frequently been associated with COVID19 with descriptions of attentional, executive, memory, and language disorders. Many studies have assessed these cognitive disturbances using online and telephone tests, often in isolated interviews on a cross-sectional design in high-income countries. Few studies evaluated the role of cognitive rehabilitation in this situation.
Objective: To characterize the cognitive profile and psychological batteries of this population pre-and post-cognitive rehabilitation after 6 months. We selected patients younger than 65 years of age with COVID19 and cognitive symptoms for more than 3 and less than 6 months and no records of previous neurodegenerative or severe psychiatric diseases. They were evaluated 3 times (0, 3, and 6 months) with cognitive battery tests and questionnaires and later by a neuropsychologist for evaluation and cognitive training.
46 patients were recruited; 41 matched the inclusion criteria and were referred to cognitive rehabilitation. 33 finished the third medical assessment. General and demographic data are shown in Table 1. Cognitive assessment in the first evaluation is demonstrated in Table 2. Only 32% of the sample had an unremarkable evaluation, and 68% were classified as having Cognitive impairment no dementia (CIND). Table 3 demonstrates patients that completed the follow-up and the changes in cognitive tests at 6 months after rehabilitation, showing a statistically significant (p |
doi_str_mv | 10.1002/alz.091999 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3151202869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151202869</sourcerecordid><originalsourceid>FETCH-LOGICAL-p565-c5669e6fe301b79121f74ca5a75242e5c88ca9a534c3fb010fbf38def09180813</originalsourceid><addsrcrecordid>eNpNj71PwzAUxC0EoqWwsLAhRpaU9-y8xB5RVD6kIpbu0YtrS0bOB3EzwF9PJIrEdDec7n4nxDXCGgHkA8fvNRg0xpyIJRLJjGRpTv_5hbhI6QMgB410LhbKlARS0lLcVDF0wXK8e-MueJcOfAh9ly7FmeeY3NVRV2L3tNlVL9n2_fm1etxmAxWUWSoK4wrvFGBTGpToy9wycUkyl46s1pYNk8qt8g0g-MYrvXd-xtUzi1qJ-9_aYew_p3m9bkOyLkbuXD-lWiGhBKkLM0dvj9Gpad2-HsbQ8vhV_31RP5LGSEY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151202869</pqid></control><display><type>article</type><title>Clinical Manifestations</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>Wiley Online Library Journals Frontfile Complete</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Spera, Raphael Ribeiro ; de Luca E Tuma, Raphael ; Rodrigues, Júlia Chartouni ; Peixoto, Satiko Andrezza Takano ; Neto, Adalberto Studart ; Miotto, Eliane C ; Coutinho, Artur Martins ; Brucki, Sonia Maria Dozzi</creator><creatorcontrib>Spera, Raphael Ribeiro ; de Luca E Tuma, Raphael ; Rodrigues, Júlia Chartouni ; Peixoto, Satiko Andrezza Takano ; Neto, Adalberto Studart ; Miotto, Eliane C ; Coutinho, Artur Martins ; Brucki, Sonia Maria Dozzi</creatorcontrib><description>Post-COVID19 syndrome is characterized by signs and symptoms that occur within 3 months of the onset of COVID19 acute phase and last at least 2 months. In the past 3 years, cognitive impairment has frequently been associated with COVID19 with descriptions of attentional, executive, memory, and language disorders. Many studies have assessed these cognitive disturbances using online and telephone tests, often in isolated interviews on a cross-sectional design in high-income countries. Few studies evaluated the role of cognitive rehabilitation in this situation.
Objective: To characterize the cognitive profile and psychological batteries of this population pre-and post-cognitive rehabilitation after 6 months. We selected patients younger than 65 years of age with COVID19 and cognitive symptoms for more than 3 and less than 6 months and no records of previous neurodegenerative or severe psychiatric diseases. They were evaluated 3 times (0, 3, and 6 months) with cognitive battery tests and questionnaires and later by a neuropsychologist for evaluation and cognitive training.
46 patients were recruited; 41 matched the inclusion criteria and were referred to cognitive rehabilitation. 33 finished the third medical assessment. General and demographic data are shown in Table 1. Cognitive assessment in the first evaluation is demonstrated in Table 2. Only 32% of the sample had an unremarkable evaluation, and 68% were classified as having Cognitive impairment no dementia (CIND). Table 3 demonstrates patients that completed the follow-up and the changes in cognitive tests at 6 months after rehabilitation, showing a statistically significant (p<0,05) improvement on some specific tests and questionnaires: Forward digit span, delayed memory on brief cognitive screening battery, lexical fluency (F-A-S), Boston naming test-15, cognitive function instrument, geriatric anxiety inventory, and geriatric depression scale.
Post-COVID-19 syndrome and cognitive impairment are relatively common also in mild infection and healthy adult patients. After cognitive rehabilitation, we depicted significant results in attention, episodic memory, verbal fluency, and psychiatric symptoms.</description><identifier>ISSN: 1552-5279</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.091999</identifier><identifier>PMID: 39750225</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Cognitive Dysfunction ; COVID-19 - complications ; COVID-19 - psychology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Neuropsychological Tests - statistics & numerical data ; Post-Acute COVID-19 Syndrome ; SARS-CoV-2</subject><ispartof>Alzheimer's & dementia, 2024-12, Vol.20 Suppl 3, p.e091999</ispartof><rights>2024 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39750225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spera, Raphael Ribeiro</creatorcontrib><creatorcontrib>de Luca E Tuma, Raphael</creatorcontrib><creatorcontrib>Rodrigues, Júlia Chartouni</creatorcontrib><creatorcontrib>Peixoto, Satiko Andrezza Takano</creatorcontrib><creatorcontrib>Neto, Adalberto Studart</creatorcontrib><creatorcontrib>Miotto, Eliane C</creatorcontrib><creatorcontrib>Coutinho, Artur Martins</creatorcontrib><creatorcontrib>Brucki, Sonia Maria Dozzi</creatorcontrib><title>Clinical Manifestations</title><title>Alzheimer's & dementia</title><addtitle>Alzheimers Dement</addtitle><description>Post-COVID19 syndrome is characterized by signs and symptoms that occur within 3 months of the onset of COVID19 acute phase and last at least 2 months. In the past 3 years, cognitive impairment has frequently been associated with COVID19 with descriptions of attentional, executive, memory, and language disorders. Many studies have assessed these cognitive disturbances using online and telephone tests, often in isolated interviews on a cross-sectional design in high-income countries. Few studies evaluated the role of cognitive rehabilitation in this situation.
Objective: To characterize the cognitive profile and psychological batteries of this population pre-and post-cognitive rehabilitation after 6 months. We selected patients younger than 65 years of age with COVID19 and cognitive symptoms for more than 3 and less than 6 months and no records of previous neurodegenerative or severe psychiatric diseases. They were evaluated 3 times (0, 3, and 6 months) with cognitive battery tests and questionnaires and later by a neuropsychologist for evaluation and cognitive training.
46 patients were recruited; 41 matched the inclusion criteria and were referred to cognitive rehabilitation. 33 finished the third medical assessment. General and demographic data are shown in Table 1. Cognitive assessment in the first evaluation is demonstrated in Table 2. Only 32% of the sample had an unremarkable evaluation, and 68% were classified as having Cognitive impairment no dementia (CIND). Table 3 demonstrates patients that completed the follow-up and the changes in cognitive tests at 6 months after rehabilitation, showing a statistically significant (p<0,05) improvement on some specific tests and questionnaires: Forward digit span, delayed memory on brief cognitive screening battery, lexical fluency (F-A-S), Boston naming test-15, cognitive function instrument, geriatric anxiety inventory, and geriatric depression scale.
Post-COVID-19 syndrome and cognitive impairment are relatively common also in mild infection and healthy adult patients. After cognitive rehabilitation, we depicted significant results in attention, episodic memory, verbal fluency, and psychiatric symptoms.</description><subject>Adult</subject><subject>Cognitive Dysfunction</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - psychology</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests - statistics & numerical data</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>SARS-CoV-2</subject><issn>1552-5279</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj71PwzAUxC0EoqWwsLAhRpaU9-y8xB5RVD6kIpbu0YtrS0bOB3EzwF9PJIrEdDec7n4nxDXCGgHkA8fvNRg0xpyIJRLJjGRpTv_5hbhI6QMgB410LhbKlARS0lLcVDF0wXK8e-MueJcOfAh9ly7FmeeY3NVRV2L3tNlVL9n2_fm1etxmAxWUWSoK4wrvFGBTGpToy9wycUkyl46s1pYNk8qt8g0g-MYrvXd-xtUzi1qJ-9_aYew_p3m9bkOyLkbuXD-lWiGhBKkLM0dvj9Gpad2-HsbQ8vhV_31RP5LGSEY</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Spera, Raphael Ribeiro</creator><creator>de Luca E Tuma, Raphael</creator><creator>Rodrigues, Júlia Chartouni</creator><creator>Peixoto, Satiko Andrezza Takano</creator><creator>Neto, Adalberto Studart</creator><creator>Miotto, Eliane C</creator><creator>Coutinho, Artur Martins</creator><creator>Brucki, Sonia Maria Dozzi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Clinical Manifestations</title><author>Spera, Raphael Ribeiro ; de Luca E Tuma, Raphael ; Rodrigues, Júlia Chartouni ; Peixoto, Satiko Andrezza Takano ; Neto, Adalberto Studart ; Miotto, Eliane C ; Coutinho, Artur Martins ; Brucki, Sonia Maria Dozzi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p565-c5669e6fe301b79121f74ca5a75242e5c88ca9a534c3fb010fbf38def09180813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Cognitive Dysfunction</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - psychology</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests - statistics & numerical data</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spera, Raphael Ribeiro</creatorcontrib><creatorcontrib>de Luca E Tuma, Raphael</creatorcontrib><creatorcontrib>Rodrigues, Júlia Chartouni</creatorcontrib><creatorcontrib>Peixoto, Satiko Andrezza Takano</creatorcontrib><creatorcontrib>Neto, Adalberto Studart</creatorcontrib><creatorcontrib>Miotto, Eliane C</creatorcontrib><creatorcontrib>Coutinho, Artur Martins</creatorcontrib><creatorcontrib>Brucki, Sonia Maria Dozzi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer's & dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spera, Raphael Ribeiro</au><au>de Luca E Tuma, Raphael</au><au>Rodrigues, Júlia Chartouni</au><au>Peixoto, Satiko Andrezza Takano</au><au>Neto, Adalberto Studart</au><au>Miotto, Eliane C</au><au>Coutinho, Artur Martins</au><au>Brucki, Sonia Maria Dozzi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Manifestations</atitle><jtitle>Alzheimer's & dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2024-12</date><risdate>2024</risdate><volume>20 Suppl 3</volume><spage>e091999</spage><pages>e091999-</pages><issn>1552-5279</issn><eissn>1552-5279</eissn><abstract>Post-COVID19 syndrome is characterized by signs and symptoms that occur within 3 months of the onset of COVID19 acute phase and last at least 2 months. In the past 3 years, cognitive impairment has frequently been associated with COVID19 with descriptions of attentional, executive, memory, and language disorders. Many studies have assessed these cognitive disturbances using online and telephone tests, often in isolated interviews on a cross-sectional design in high-income countries. Few studies evaluated the role of cognitive rehabilitation in this situation.
Objective: To characterize the cognitive profile and psychological batteries of this population pre-and post-cognitive rehabilitation after 6 months. We selected patients younger than 65 years of age with COVID19 and cognitive symptoms for more than 3 and less than 6 months and no records of previous neurodegenerative or severe psychiatric diseases. They were evaluated 3 times (0, 3, and 6 months) with cognitive battery tests and questionnaires and later by a neuropsychologist for evaluation and cognitive training.
46 patients were recruited; 41 matched the inclusion criteria and were referred to cognitive rehabilitation. 33 finished the third medical assessment. General and demographic data are shown in Table 1. Cognitive assessment in the first evaluation is demonstrated in Table 2. Only 32% of the sample had an unremarkable evaluation, and 68% were classified as having Cognitive impairment no dementia (CIND). Table 3 demonstrates patients that completed the follow-up and the changes in cognitive tests at 6 months after rehabilitation, showing a statistically significant (p<0,05) improvement on some specific tests and questionnaires: Forward digit span, delayed memory on brief cognitive screening battery, lexical fluency (F-A-S), Boston naming test-15, cognitive function instrument, geriatric anxiety inventory, and geriatric depression scale.
Post-COVID-19 syndrome and cognitive impairment are relatively common also in mild infection and healthy adult patients. After cognitive rehabilitation, we depicted significant results in attention, episodic memory, verbal fluency, and psychiatric symptoms.</abstract><cop>United States</cop><pmid>39750225</pmid><doi>10.1002/alz.091999</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5279 |
ispartof | Alzheimer's & dementia, 2024-12, Vol.20 Suppl 3, p.e091999 |
issn | 1552-5279 1552-5279 |
language | eng |
recordid | cdi_proquest_miscellaneous_3151202869 |
source | MEDLINE; Wiley Online Library Open Access; Wiley Online Library Journals Frontfile Complete; PubMed Central; PubMed Central Open Access |
subjects | Adult Cognitive Dysfunction COVID-19 - complications COVID-19 - psychology Cross-Sectional Studies Female Humans Male Middle Aged Neuropsychological Tests - statistics & numerical data Post-Acute COVID-19 Syndrome SARS-CoV-2 |
title | Clinical Manifestations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T07%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Manifestations&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Spera,%20Raphael%20Ribeiro&rft.date=2024-12&rft.volume=20%20Suppl%203&rft.spage=e091999&rft.pages=e091999-&rft.issn=1552-5279&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.091999&rft_dat=%3Cproquest_pubme%3E3151202869%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151202869&rft_id=info:pmid/39750225&rfr_iscdi=true |